FRANCISCA PAZ: Open Payments
NPI 1992325682 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,637 in 59 payments from 13 companies in 2025. Trend: 2023 $1,299 · 2024 $3,377 · 2025 $2,637
Food & beverage: $1,319Travel & lodging: $1,318
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 12 | $1,813 |
| Novartis Pharmaceuticals Corporation | 28 | $337 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $152 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| PFIZER INC. | 3 | $53 |
| Stryker Corporation | 1 | $36 |
| Amgen Inc. | 2 | $35 |
| Actelion Pharmaceuticals US, Inc. | 1 | $31 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
Products named: COREVALVE EVOLUT R, SYMPLICITY G3, LEQVIO, Kerendia, AFFERA MAPPING SYSTEM, ELIQUIS, FLOWTRIEVER, REPATHA.
Industry payments across TX — which companies pay providers there.
